Wei Jiang - 12 Mar 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role: Director
Signature: /s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang
Issuer symbol: STAA
Transactions as of: 12 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Mar 2024, 17:11:44 UTC
Previous filing: 03 Jan 2024
Next filing: 01 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STAA	Common Stock	Award	$0	+1,299		$0.000000	1,299	12 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STAA	Restricted Stock Units	Award	$0	+1,061		$0.000000	1,061	12 Mar 2024	Common Stock	1,061	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Effective March 12, 2024, the Board of Directors appointed Mr. Jiang to serve as a member of the Board and granted him, as a non-employee director, 1,299 restricted shares, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.
F2	Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F3	RSUs granted as compensation for services as a director to non-employee directors who elected to receive shares in lieu of director cash compensation fees. Mr. Jiang has elected to defer delivery of these shares.